EBC-170065
Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
102767-28-2
Purity
95%
Levetiracetam is an antiepileptic agent that binds to the synaptic vesicle protein SV2A. It is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older.
Properties
Name
Levetiracetam
Smiles
CC[C@H](N1CCCC1=O)C(=O)N
Targets
Please log in to see this information
SDS
(2S)-(2-oxo-1-pyrrolidinyl)butanamide | (2S)-2-(2-oxopyrrolidin-1-yl)butanamide | (S)-(-)-α-ethyl-2-oxo-1-pyrrolidineacetamide | (S)-2-(2-oxopyrrolidin-1-yl)butanamide | keppra | levetiracetam
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
(2S)-(2-oxo-1-pyrrolidinyl)butanamide | (2S)-2-(2-oxopyrrolidin-1-yl)butanamide | (S)-(-)-α-ethyl-2-oxo-1-pyrrolidineacetamide | (S)-2-(2-oxopyrrolidin-1-yl)butanamide | keppra | levetiracetam
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.